How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
New study identifies the optimal exercise dose for reducing hepatic steatosis
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not only drives…
Groundbreaking 3D dynamic cell co-culture models simulate MASLD progression
In a recent work published in BME Frontiers, a collaborative study by researchers from Griffith University, Queensland University…